Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

A Massive Study of 250,000 Patients Just Revealed a Surprising New Use for GLP-1s

A new Mayo Clinic analysis of more than 250,000 health records reveals that GLP-1 drugs could outperform metformin in reversing prediabetes and lowering heart risks.

A Massive Study of 250,000 Patients Just Revealed a Surprising New Use for GLP-1s

We haven't written up this one. Inc. has the full story — the link below goes straight to it.

Read the original at inc.com →

Report a problem with this story

More in Health & Medicine

More from Saturday 21 November →